1887

Microbiology Society logo

Volume 147, Issue 9

HO-nonproducing strains: survival in stationary phase and virulence in chronic granulomatous disease Free

Abstract

The production of hydrogen peroxide (HO) and related phenotypes were studied with strains isolated from cases of pharyngitis or severe group A streptococcal infections. Of the 46 strains examined (34 from severe infections and 12 from pharyngitis cases), 25 strains accumulated HO in the culture medium when grown under glucose-limited, aerobic conditions, whereas the rest of the strains did not. There was no correlation between these traits and the type of disease from which each strain had been isolated. The HO-nonproducing strains tested in this study belonged to T type 3 or T type 12. The accumulation of HO started when the culture reached the late exponential phase. A rapid loss of cell viability accompanied HO accumulation but was completely prevented by the addition of a catalase, indicating that the lethality was actually caused by HO. Cells of HO-nonproducing strains were resistant to killing by phagocytes from patients with chronic granulomatous disease (CGD), whereas those of HO-producing strains were subject to killing. Subcutaneous inoculation of 10 c.f.u. HO-nonproducing strains into the hind footpads of CGD mice provoked more prominent swelling of the footpad than did HO-producing strains. The mortality rate in the CGD mice infected with the HO-nonproducing strains was higher than that produced by the HO-producing strains. It is suggested that HO-nonproducing strains are prevalent in humans and that they may be a potential threat to the health of CGD patients.

  • Received:
  • Accepted:
  • Revised:
  • Published Online:
Keyword(s): BHI, brain-heart infusion , CGD , CGD, chronic granulomatous disease , gp91-phox knockout mice , group A streptococci and hydrogen peroxide
© Microbiology Society
Loading

Article metrics loading...

/content/journal/micro/10.1099/00221287-147-9-2469
2001-09-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/micro/147/9/1472469a.html?itemId=/content/journal/micro/10.1099/00221287-147-9-2469&mimeType=html&fmt=ahah

References

  1. Cleary P. P., Larkin A. 1979; Hyaluronic acid capsule: strategy for oxygen resistance in group A streptococci. J Bacteriol 140:1090–1097
     [Google Scholar]
  2. Gallin J. I., Buescher E. S., Seilingmann B. E., Nath J., Gaither T. E., Katz P. 1983; Recent advances in chronic granulomatous disease. Ann Intern Med 99:657–674 [CrossRef]
     [Google Scholar]
  3. Garcia-Mendoza A., Liebana J., Castillo A. M., de la Higuera A., Piedrola G. 1993; Evaluation of the capacity of oral streptococci to produce hydrogen peroxide. J Med Microbiol 39:434–439 [CrossRef]
     [Google Scholar]
  4. Gibson C. M., Mallett T. C., Claiborne A., Caparon M. G. 2000; Contribution of NADH oxidase to aerobic metabolism of Streptococcus pyogenes . J Bacteriol 182:448–455 [CrossRef]
     [Google Scholar]
  5. Guilbault G. G., Brignac P. J., Zimmer M. 1966; Homovanillic acid as a fluorometric substrate for oxidative enzyme. Anal Chem 38:190–196 [CrossRef]
     [Google Scholar]
  6. Hiemstra P. S., Annema A., Schippers E. F., van Furth R. 1992; Pertussis toxin partially inhibits phagocytosis of immunoglobulin G-opsonized Staphylococcus aureus by human granulocytes but does not affect intracellular killing. Infect Immun 60:202–205
     [Google Scholar]
  7. Holm S. E., Norrby A., Bergholm A. M., Norgren M. 1992; Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988–1989. J Infect Dis 166:31–37 [CrossRef]
     [Google Scholar]
  8. Holmberg K., Hallander H. O. 1973; Production of bactericidal concentrations of hydrogen peroxide by Streptococcus sanguis . Arch Oral Biol 18:423–434 [CrossRef]
     [Google Scholar]
  9. Jackson S. H., Gallin J. I., Holland S. M. 1995; The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med 182:751–758 [CrossRef]
     [Google Scholar]
  10. Jeong J. S., Kwon S. J., Kang S. W., Rhee S. G., Kim K. 1999; Purification and characterization of a second type thioredoxin peroxidase (type II TPx) from Saccharomyces cerevisiae . Biochemistry 38:776–783 [CrossRef]
     [Google Scholar]
  11. Kaplan E. L., Laxdal T., Quie P. G. 1968; Studies of polymorphonuclear leukocytes from patients with chronic granulomatous disease of childhood: bactericidal capacity for streptococci. Pediatrics 41:591–599
     [Google Scholar]
  12. LeBien T. W., Bromel M. C. 1975; Antibacterial properties of a peroxidogenic strain of Streptococcus mitior ( mitis ). Can J Microbiol 21:101–103 [CrossRef]
     [Google Scholar]
  13. Liebana J., Parejo E., Castillo A., Gutierrez J. 1993; Phenotypic characterization of oral streptococci by classical methods. Microbios 76:7–18
     [Google Scholar]
  14. Lyon W. R., Gibson C. M., Caparon M. G. 1998; A role for trigger factor and an rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes . EMBO J 17:6263–6275 [CrossRef]
     [Google Scholar]
  15. McLeod J. W., Gordon J. 1922; Production of hydrogen peroxide by bacteria. Biochem J 16:499–504
     [Google Scholar]
  16. Marty-Teysset C., de la Torre F., Garel J.-R. 2000; Increased production of hydrogen peroxide by Lactobacillus delbrueckii subsp. bulgaricus upon aeration: involvement of an NADH oxidase in oxidative stress. Appl Environ Microbiol 66:262–267 [CrossRef]
     [Google Scholar]
  17. Murphy M. G., Condon S. 1984; Correlation of oxygen utilization and hydrogen peroxide accumulation with oxygen induced enzymes in Lactobacillus plantarum cultures. Arch Microbiol 138:44–48 [CrossRef]
     [Google Scholar]
  18. Nagatomo T., Ohga S., Saito M., Takada H., Sasaki Y., Okada K., Inamura T., Hara T. 1999; Streptococcus intermedius -brain abscess in chronic granulomatous disease. Eur J Pediatr 158:872–873 [CrossRef]
     [Google Scholar]
  19. Pollock J. D., Williams D. A., Gifford M. A., Li L. L., Du X., Fisherman J., Orkin S. H., Doerschuk C. M., Dinauer M. C. 1995; Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 9:202–209 [CrossRef]
     [Google Scholar]
  20. Regelmann W., Hays N., Quie P. G. 1983; Chronic granulomatous disease: historical perspective and clinical experience at the University of Minnesota Hospital. Adv Host Def Mech 3:3–23
     [Google Scholar]
  21. Roos D. 1994; The genetic basis of chronic granulomatous disease. Immunol Rev 138:121–157 [CrossRef]
     [Google Scholar]
  22. Rotta J., Facklam R. R. 1980; Type identification of group A streptococci. Manual of Microbiological Diagnostic Methods for Streptococcal Infections and their Sequelae 25–35 Geneva: World Health Organization;
     [Google Scholar]
  23. Russell J. B., Diez-Gonzalez F. 1998; The effects of fermentation acids on bacterial growth. Adv Microb Physiol 39:205–234
     [Google Scholar]
  24. Segal B. H., Leto T. L., Gallin J. I., Malech H. L., Holland S. M. 2000; Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine 79:170–200 [CrossRef]
     [Google Scholar]
  25. Shanley T. P., Schrier D., Kapur V., Kehoe M., Musser J. M., Ward P. A. 1996; Streptococcal cysteine protease augments lung injury induced by products of group A streptococci. Infect Immun 64:870–877
     [Google Scholar]
  26. Shimokawa O., Nakayama H. 1999; Acetate-mediated growth inhibition in sterol 14 alpha-demethylation-deficient cells of Candida albicans . Antimicrob Agents Chemother 43:100–105
     [Google Scholar]
  27. Spellerberg B., Cundell D. R., Sandros J., Pearce B. J., Idanpaan-Heikkila I., Rosenow C., Masure R. 1996; Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae . Mol Microbiol 19:803–813 [CrossRef]
     [Google Scholar]
  28. Stouthamer A. H. 1978; Energy-yielding pathways. In The Bacteria pp 389–462 Edited by Ornston L. N., Sokatch J. R. New York: Academic Press;
     [Google Scholar]
  29. Talkington D. F., Schwartz B., Black C. M., Todd J. K., Elliott J., Breiman R. F., Facklam R. R. 1993; Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun 61:3369–3374
     [Google Scholar]
  30. Thomas E. L., Pera K. A. 1983; Oxygen metabolism of Streptococcus mutans : uptake of oxygen and release of superoxide and hydrogen peroxide. J Bacteriol 154:1236–1244
     [Google Scholar]
  31. Ukada S., Koukol J., Vennesland B. 1959; Lactic oxidase of the pneumococcus. J Bacteriol 78:714–725
     [Google Scholar]
  32. Whiley R. A., Fraser H., Hardie J. M., Beighton D. 1990; Phenotypic differentiation of Streptococcus intermedius , Streptococcus constellatus , and Streptococcus anginosus strain within the ‘‘ Streptococcus milleri Group’’. J Clin Microbiol 28:1497–1501
     [Google Scholar]
  33. Willcox M. D. P., Drucker D. B. 1988; Partial characterisation of the inhibitory substances produced by Streptococcus oralis and related spieces. Microbios 55:135–145
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/00221287-147-9-2469
Loading
H2O2-nonproducing Streptococcus pyogenes strains: survival in stationary phase and virulence in chronic granulomatous disease
Microbiology 147, 2469 (2001); https://doi.org/10.1099/00221287-147-9-2469
/content/journal/micro/10.1099/00221287-147-9-2469
/content/journal/micro/10.1099/00221287-147-9-2469
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error